MGTA Annual CFI
-$9.81 M
-$53.24 M-122.59%
31 December 2022
Summary:
As of January 21, 2025, MGTA annual cash flow from investing activities is -$9.81 million, with the most recent change of -$53.24 million (-122.59%) on December 31, 2022. During the last 3 years, it has fallen by -$11.34 million (-740.47%).MGTA Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MGTA Quarterly CFI
$18.87 M
-$7.62 M-28.77%
30 June 2023
Summary:
As of January 21, 2025, MGTA quarterly cash flow from investing activities is $18.87 million, with the most recent change of -$7.62 million (-28.77%) on June 30, 2023. Over the past year, it has increased by +$19.00 million (+14731.01%).MGTA Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MGTA TTM CFI
$75.83 M
+$19.00 M+33.44%
30 June 2023
Summary:
As of January 21, 2025, MGTA TTM cash flow from investing activities is $75.83 million, with the most recent change of +$19.00 million (+33.44%) on June 30, 2023. Over the past year, it has increased by +$110.06 million (+321.55%).MGTA TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MGTA Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -122.6% | +10000.0% | +321.6% |
| 3 y3 years | -740.5% | +26.1% | -23.0% |
| 5 y5 years | -346.2% | +2904.5% | +4849.8% |
MGTA Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -122.6% | -70.4% | -23.0% |
Magenta Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | $18.87 M(-28.8%) | $75.83 M(+33.4%) |
| Mar 2023 | - | $26.50 M(+74.1%) | $56.83 M(-679.2%) |
| Dec 2022 | -$9.81 M(-122.6%) | $15.22 M(-0.1%) | -$9.81 M(-72.2%) |
| Sept 2022 | - | $15.24 M(<-9900.0%) | -$35.35 M(+3.3%) |
| June 2022 | - | -$129.00 K(-99.7%) | -$34.23 M(+713.2%) |
| Mar 2022 | - | -$40.14 M(+288.9%) | -$4.21 M(-109.7%) |
| Dec 2021 | $43.43 M(-508.3%) | -$10.32 M(-163.1%) | $43.43 M(-352.2%) |
| Sept 2021 | - | $16.37 M(-45.2%) | -$17.22 M(+26.5%) |
| June 2021 | - | $29.89 M(+298.9%) | -$13.61 M(-52.3%) |
| Mar 2021 | - | $7.49 M(-110.6%) | -$28.54 M(+168.3%) |
| Dec 2020 | -$10.63 M | -$70.97 M(-455.2%) | -$10.63 M(-119.5%) |
| Sept 2020 | - | $19.98 M(+33.5%) | $54.62 M(-44.5%) |
| June 2020 | - | $14.96 M(-41.1%) | $98.44 M(+148.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | $25.39 M(-543.7%) | $39.66 M(+2488.6%) |
| Dec 2019 | $1.53 M(-101.7%) | -$5.72 M(-109.0%) | $1.53 M(-101.9%) |
| Sept 2019 | - | $63.81 M(-245.6%) | -$81.14 M(-45.0%) |
| June 2019 | - | -$43.82 M(+244.2%) | -$147.42 M(+41.4%) |
| Mar 2019 | - | -$12.73 M(-85.6%) | -$104.27 M(+13.7%) |
| Dec 2018 | -$91.70 M(+4070.2%) | -$88.39 M(+3471.5%) | -$91.70 M(+2526.8%) |
| Sept 2018 | - | -$2.48 M(+267.8%) | -$3.49 M(+149.2%) |
| June 2018 | - | -$673.00 K(+318.0%) | -$1.40 M(-14.0%) |
| Mar 2018 | - | -$161.00 K(-11.5%) | -$1.63 M(-25.9%) |
| Dec 2017 | -$2.20 M(+1482.0%) | -$182.00 K(-52.7%) | -$2.20 M(+9.0%) |
| Sept 2017 | - | -$385.00 K(-57.3%) | -$2.02 M(+23.6%) |
| June 2017 | - | -$901.00 K(+23.3%) | -$1.63 M(+123.3%) |
| Mar 2017 | - | -$731.00 K | -$731.00 K |
| Dec 2016 | -$139.00 K | - | - |
FAQ
- What is Magenta Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Magenta Therapeutics?
- What is Magenta Therapeutics annual CFI year-on-year change?
- What is Magenta Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Magenta Therapeutics?
- What is Magenta Therapeutics quarterly CFI year-on-year change?
- What is Magenta Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Magenta Therapeutics?
- What is Magenta Therapeutics TTM CFI year-on-year change?
What is Magenta Therapeutics annual cash flow from investing activities?
The current annual CFI of MGTA is -$9.81 M
What is the all time high annual CFI for Magenta Therapeutics?
Magenta Therapeutics all-time high annual cash flow from investing activities is $43.43 M
What is Magenta Therapeutics annual CFI year-on-year change?
Over the past year, MGTA annual cash flow from investing activities has changed by -$53.24 M (-122.59%)
What is Magenta Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of MGTA is $18.87 M
What is the all time high quarterly CFI for Magenta Therapeutics?
Magenta Therapeutics all-time high quarterly cash flow from investing activities is $63.81 M
What is Magenta Therapeutics quarterly CFI year-on-year change?
Over the past year, MGTA quarterly cash flow from investing activities has changed by +$19.00 M (+14731.01%)
What is Magenta Therapeutics TTM cash flow from investing activities?
The current TTM CFI of MGTA is $75.83 M
What is the all time high TTM CFI for Magenta Therapeutics?
Magenta Therapeutics all-time high TTM cash flow from investing activities is $98.44 M
What is Magenta Therapeutics TTM CFI year-on-year change?
Over the past year, MGTA TTM cash flow from investing activities has changed by +$110.06 M (+321.55%)